Cargando…
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and th...
Autores principales: | Briano, Federica, Magnasco, Laura, Sepulcri, Chiara, Dettori, Silvia, Dentone, Chiara, Mikulska, Malgorzata, Ball, Lorenzo, Vena, Antonio, Robba, Chiara, Patroniti, Nicolò, Brunetti, Iole, Gratarola, Angelo, D’Angelo, Raffaele, Di Pilato, Vincenzo, Coppo, Erika, Marchese, Anna, Pelosi, Paolo, Giacobbe, Daniele Roberto, Bassetti, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995918/ https://www.ncbi.nlm.nih.gov/pubmed/35404010 http://dx.doi.org/10.1007/s40121-022-00625-9 |
Ejemplares similares
-
Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023) -
Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?
por: Magnasco, Laura, et al.
Publicado: (2021) -
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
por: Taramasso, Lucia, et al.
Publicado: (2021) -
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022) -
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit
por: Mikulska, Malgorzata, et al.
Publicado: (2022)